Understanding the Distinction There are two separate clinical scenarios that coders often confuse: Scenario A: Steroid-induced hyperglycemia (not yet diabetes) The patient has elevated blood sugar in response to steroids, but the physician has not documented a formal diabetes diagnosis
J Biol Chem (2007) 282(41):3010719
For example, if a costly biologic is under medical benefit, the patient might pay 20% coinsurance on a $10,000 infusion (i.e
Antidiabetic drugs, including intranasally administered insulin, as well as GLP-1RAs, modify the processes linking T2DM with cognitive impairment [29]
In the FLOW trial [see Clinical Studies (14.3)] in patients with type 2 diabetes mellitus and chronic kidney disease, safety data collection was limited to serious adverse events and selected predefined categories of adverse events regardless of seriousness
Pros : Potential benefits to improve insulin sensitivity in people with insulin resistance